Literature DB >> 10203199

Symptoms reported by elderly patients with isolated systolic hypertension: baseline data from the SYST-EUR trial. Systolic Hypertension in Europe.

C J Bulpitt1, A E Fletcher, L Thijs, J A Staessen, R Antikainen, C Davidson, R Fagard, B Gil-Extremera, M Jääskivi, E O'Brien, P Palatini, J Tuomilehto.   

Abstract

OBJECTIVES: To determine the symptomatic well-being of elderly persons with isolated systolic hypertension. DESIGN AND
SETTING: Well-being determined during the placebo run-in period prior to entry to the Systolic Hypertension in Europe (SYST-EUR) trial.
SUBJECTS: 641 People, 60 years or older with an average sitting blood pressure of 173/86 mm Hg. OUTCOME MEASURES: 33 Symptomatic complaints determined by a standard interview.
RESULTS: The 437 women complained of 25% of the symptoms and the 204 men 21% (P<0.001). A markedly higher prevalence was observed in women compared with men for: pain in the joints of the hands (35% of women complained of this against 22% of men); 'racing heart' (33% against 17%); dry eyes (16% against 6%); blurring of vision (35% against 23%); cramps in the legs (43% against 31%); and a sore throat (15% against 7%). Nocturia was the most frequent complaint (68% in both sexes). Eight symptoms increased with age and one (rash) tended to decline. With increasing systolic pressure women also reported more headaches, unsteadiness, blurring of vision, irregular heart beat and 'racing heart' but, of these, only headaches increased with diastolic pressure. These observations were made after adjusting for age, blood sugar and body mass index (BMI) and were not observed in men. Higher blood sugars were associated with mouth ulcers, 'racing heart', blurring of vision and cramps in the legs. A higher BMI was associated with six symptoms, and a lower age of leaving education with eight. In men, alcohol consumption was related to 'racing heart', and smoking to wheezing and having a dry cough.
CONCLUSIONS: A high level of complaint was associated with female gender, increasing age, blood sugar and BMI and a low age of leaving education.

Entities:  

Mesh:

Year:  1999        PMID: 10203199     DOI: 10.1093/ageing/28.1.15

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  5 in total

1.  Effect of elevated blood pressure on quality of life in children with chronic kidney disease.

Authors:  Cynthia Wong; Arlene Gerson; Stephen R Hooper; Matthew Matheson; Marc Lande; Juan Kupferman; Susan Furth; Bradley Warady; Joseph Flynn
Journal:  Pediatr Nephrol       Date:  2016-02-08       Impact factor: 3.714

2.  Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus.

Authors:  Nobuko Kitagawa; Emi Ushigome; Noriyuki Kitagawa; Hidetaka Ushigome; Isao Yokota; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

3.  Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients.

Authors:  Edwina A Brown; Lina Johansson; Ken Farrington; Hugh Gallagher; Tom Sensky; Fabiana Gordon; Maria Da Silva-Gane; Nigel Beckett; Mary Hickson
Journal:  Nephrol Dial Transplant       Date:  2010-04-16       Impact factor: 5.992

4.  Childhood hypertension is not a silent disease.

Authors:  Beth Croix; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

5.  Impact of Isolated High Home Systolic Blood Pressure and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A 5-Year Prospective Cohort Study.

Authors:  Nobuko Kitagawa; Noriyuki Kitagawa; Emi Ushigome; Hidetaka Ushigome; Isao Yokota; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.